0.80 (-%)
As of Nov 01, 2024
Source:
Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company transitioning in 2024 to a commercial-stage cell therapy company. We focus on providing novel cell therapies to people with cancer.
| Country | United Kingdom |
| Headquarters | abingdon,, oxfordshire |
| Phone Number | (44) 1235 430000 |
| Industry | manufacturing |
| CEO | Adrian Rawcliffe |
| Website | www.adaptimmune.com |